Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The type I collagen gene promoter refers to the regulatory DNA sequences upstream of the type I collagen genes, primarily COL1A1 and COL1A2, which control their transcription. These promoters are essential for tissue-specific and regulated expression of type I collagen, the most abundant protein in vertebrate connective tissues. Key regulatory elements include binding sites for SP1, NFκB, STAT6, and AP2. Dysregulation leads to conditions like fibrosis or genetic disorders such as osteogenesis imperfecta or Ehlers-Danlos syndrome. Mutations or polymorphisms in promoter regions can alter gene expression, such as a common polymorphism that increases osteoporosis risk. The promoter is regulated by factors like TGF-beta, IL-4 (inducing activation via STAT6), and interferon-gamma (downregulating activity).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type I Collagen Gene Promoter.